MedPath

Laparoscopic Revision Gastric Bypass for Weight Recidivism

Completed
Conditions
Weight Regain
Weight Recidivism
Obesity Recidivism
Clinically Severe Obesity
Registration Number
NCT01040572
Lead Sponsor
University of California, San Francisco
Brief Summary

The main aim of this study is to analyze and report traditional, patient-centered, and composite intermediate-term outcomes after laparoscopic revision Roux-en-Y gastric bypass surgery for weight recidivism.

Detailed Description

There is lack of standardization of primary and revisional bariatric surgery compounded by a scant long-term outcome data. The treatment of inadequate weight loss, weight recidivism, and most severe technical complications after primary bariatric surgery remains refractory to non-operative treatment. Failure rates have been reported up to 20% and 35% for the morbidly obese (MO) and super obese (SO), respectively at 2 to 3 years after surgery. The indication for further surgical intervention remains controversial, as does what type of revisional procedure, both operative and endoscopic, to recommend. Furthermore, there is no standardization of the limb lengths, pouch size or the use of prosthetic reinforcement. Therefore the approach to these patients must be as individualized as their original operations. We formally analyze our experience with all laparoscopic revisional strategies for weigh regain after failed gastric bypass.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
132
Inclusion Criteria
  • patients that underwent laparoscopic revisional "RYGB" for failed "RYGB" with weight recidivism or weight regain "WR" pattern
Read More
Exclusion Criteria
  • failed RYGB with an Inadequate Initial Weight Loss "IIWL" pattern
  • patients with prior major bariatric conversion or esophago-gastric surgeries
  • RYGB patients revised by an open surgical approach
  • RYGB patients who underwent laparoscopic revisional RYGB surgery somewhere else and continue their follow-up care with our program
  • missing records and/or unreachable patients with scant information for analysis
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weight loss expressed as Body Mass Index and Percentage Excess Weight LossAt the lowest weight loss point and at last follow-up
Comorbidity statusthroughout follow-up
Subjective Satisfactionat last follow-up
Health-Related Quality of Life (HR-QoL).at the last follow-up
Morbidity and mortalitythroughout follow-up
Secondary Outcome Measures
NameTimeMethod
To assess failuresat yearly intervals throughout follow-up
To evaluate the patients´ metabolic and nutritional statusthroughout follow-up

Trial Locations

Locations (1)

UCSF Fresno Center for Medical Education and Research

🇺🇸

Fresno, California, United States

© Copyright 2025. All Rights Reserved by MedPath